COMPASS Pathways plc (CMPS)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$466.4M
Cash & Equivalents
$47.9M
Quarterly Burn Rate
29 mo
Est. Cash Runway
$1,835M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

FDA-Related SEC Filings

DateTypeDescriptionLink
2026-07-07 8-K COMPASS Pathways plc (CMPS) (CIK 0001816590) - 8-K EDGAR

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CMPS.

SEC EDGAR Filings

All SEC filings for COMPASS Pathways plc on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.